1 例paxlovid 与他克莫司药物相互作用导致患者血糖升高的药学监护.

周炜， 蒋俊杰， 王法财 - Practical Pharmacy & Clinical …, 2024 - search.ebscohost.com
… ] A kidney transplant patient was complicated with COVID-19. … of drug-drug interactions
between the COVID-19 antiviral … with nirmatrelvir/ritonavir (Paxlovid) for COVID-19 infection in a …
相关文章
[PDF] zgxdyyzz.com.cn

[PDF][PDF] 新型冠状病毒肺炎的抗病毒治疗进展

石浩川， 潘蕾 - 中国现代医药杂志, 2024 - zgxdyyzz.com.cn
… A retrospective analysis of clinical efficacy of ribavirin in adults hospitalized with … effectiveness
of nirmatrelvir-ritonavir for reducing hospital admissions and mortality from COVID-19[J]. …
相关文章 所有 2 个版本
[PDF] lcywzlzz.com

[PDF][PDF] 新型冠状病毒感染预防药物研究进展

李奇隆， 钟武， 朱贺， 樊士勇 - 临床药物治疗杂志, 2023 - lcywzlzz.com
… of prophylaxis drugs for COVID-19,including antibody drugs … 韦/利托那韦组合物,nirmatrelvir/ritonavir),
莫诺拉韦(molnupiravir… Systematic review of the clinical effectiveness of tixagevimab/…
相关文章

Acupoint stimulation for long COVID: A promising intervention: 穴位刺激治疗长新冠: 一种有前景的干预措施

BW Feng, PJ Rong - World Journal of Acupuncture-Moxibustion, 2023 - Elsevier
… ritonavir 100 mg) alleviates some symptoms and has been approved for use in acute
COVID-19; however, Pfizer has not tested the efficacy of the … therapies to avoid drug side effects. …
被引用次数：1 相关文章 所有 4 个版本
[HTML] nih.gov

[HTML][HTML] Acupoint stimulation for long COVID: A promising intervention: 穴位刺激治疗长新冠: 一种有前景的干预措施

BW Feng, PJ Rong - World Journal of Acupuncture-Moxibustion - ncbi.nlm.nih.gov
… ritonavir 100 mg) alleviates some symptoms and has been approved for use in acute
COVID-19; however, Pfizer has not tested the efficacy of the … therapies to avoid drug side effects. …
相关文章

成人恶性肿瘤患者合并新型冠状病毒感染的诊治建议.

胡毅 - Chinese Journal of Oncology/Zhonghua Zhongliu …, 2023 - search.ebscohost.com
… 2020年初报道的武 汉COVID⁃19疫情中,肿瘤患者数据显示,COVID⁃19 患者中18例有恶性肿瘤
… Drug⁃drug interactions between ritonavir⁃boosted nirmatrelvir (Paxlovid) and concomitant …
相关文章 所有 2 个版本